2018
DOI: 10.1103/physrevfluids.3.093601
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of multiple drops and formation of toroidal-spiral particles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 141 publications
0
1
0
Order By: Relevance
“…Here, we present a particulate technology that can be potentially used for ACT delivery by a minimally invasive procedure to the tumor mass with well-controlled microenvironment for in vivo cell proliferation, activation, and release. These heterogeneous particles with toroidal-spiral (TS) internal structures were generated by a self-assembly process of polymeric droplet sedimentation in a miscible solution and subsequent polymer solidification initiated by a ultraviolet (UV) beam. , We previously demonstrated that these toroidal-spiral particles (TSPs) could be used for codelivery and controlled release of therapeutic agents of different sizes, such as a small molecular drug and a full-size antibody . The TSPs can have enormous flexibility for delivery of various therapeutic agents, including living cells.…”
Section: Introductionmentioning
confidence: 99%
“…Here, we present a particulate technology that can be potentially used for ACT delivery by a minimally invasive procedure to the tumor mass with well-controlled microenvironment for in vivo cell proliferation, activation, and release. These heterogeneous particles with toroidal-spiral (TS) internal structures were generated by a self-assembly process of polymeric droplet sedimentation in a miscible solution and subsequent polymer solidification initiated by a ultraviolet (UV) beam. , We previously demonstrated that these toroidal-spiral particles (TSPs) could be used for codelivery and controlled release of therapeutic agents of different sizes, such as a small molecular drug and a full-size antibody . The TSPs can have enormous flexibility for delivery of various therapeutic agents, including living cells.…”
Section: Introductionmentioning
confidence: 99%